David Kavtaradze MD, Inc.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes5 trials
• Type 1 diabetes2 trials

Phase

• Phase 23 trials
• Phase 1/21 trial
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Biomea Fusion Inc.3 trials
• Housey Healthcare ULC1 trial
• Novo Nordisk A/S1 trial

Running trials

• Recruiting

  AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  NCT07797335· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  NCT07502508· Phase 2· Biomea Fusion Inc.· Source

  Contact: Biomea Fusion Inc.

• Active, not recruiting

  Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

  NCT07502495· Phase 2· Biomea Fusion Inc.· Source

• Recruiting

  HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  NCT07546929· Phase 2· Housey Healthcare ULC· Source

  Contact: David Kavtaradze, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes3 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

  NCT05731544· Phase 1/2· Biomea Fusion Inc.· Source